https://www.selleckchem.com/pr....oducts/salinomycin.h
At-admission hyperglycemia have been associated with poorer outcome during critical illnesses. At-admission hyperglycemia in previously unknown diabetes is not uncommonly encountered entity in patients with COVID-19. We sought to find out the outcomes of at-admission hyperglycemia and effect of early intervention to achieve optimal glycemic control in relation to COVID-19 patients. We searched the PubMed and Google Scholar database up till August 20, 2020 using specific keywords related to our aims and objectives. All currently avai
Like
Comment
Share
